DA Cox

795 total citations
8 papers, 543 citations indexed

About

DA Cox is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pharmacology. According to data from OpenAlex, DA Cox has authored 8 papers receiving a total of 543 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cardiology and Cardiovascular Medicine, 3 papers in Surgery and 1 paper in Pharmacology. Recurrent topics in DA Cox's work include Coronary Interventions and Diagnostics (3 papers), Antiplatelet Therapy and Cardiovascular Diseases (2 papers) and Acute Myocardial Infarction Research (2 papers). DA Cox is often cited by papers focused on Coronary Interventions and Diagnostics (3 papers), Antiplatelet Therapy and Cardiovascular Diseases (2 papers) and Acute Myocardial Infarction Research (2 papers). DA Cox collaborates with scholars based in United States and United Kingdom. DA Cox's co-authors include Gregg W. Stone, Roxana Mehran, Michael G. McLaughlin, Costantino O. Costantini, James E. Tcheng, A.J. Lansky, Paul Sorajja, Peter Zimetbaum, Cindy L. Grines and Gregory W. Stone and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and European Heart Journal.

In The Last Decade

DA Cox

7 papers receiving 529 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
DA Cox United States 5 448 394 261 49 29 8 543
Gisbert Kober Germany 14 390 0.9× 296 0.8× 218 0.8× 99 2.0× 7 0.2× 33 541
Alan Soward Netherlands 10 327 0.7× 291 0.7× 261 1.0× 61 1.2× 10 0.3× 16 465
Pierre Y. Tilmant France 9 578 1.3× 178 0.5× 427 1.6× 41 0.8× 11 0.4× 13 683
Karen Stocke United States 11 436 1.0× 197 0.5× 243 0.9× 37 0.8× 17 0.6× 17 542
J. A. Salerno Italy 18 988 2.2× 174 0.4× 400 1.5× 30 0.6× 8 0.3× 47 1.1k
A Maresta Italy 12 489 1.1× 505 1.3× 193 0.7× 109 2.2× 7 0.2× 50 683
Steven Blumlein United States 8 304 0.7× 145 0.4× 86 0.3× 34 0.7× 39 1.3× 12 423
G. P. Trevi Italy 12 238 0.5× 109 0.3× 92 0.4× 29 0.6× 13 0.4× 31 365
Satoru Otsuji Japan 12 377 0.8× 520 1.3× 304 1.2× 172 3.5× 16 0.6× 42 671
Silvio E. Papapietro United States 13 451 1.0× 207 0.5× 207 0.8× 72 1.5× 109 3.8× 29 573

Countries citing papers authored by DA Cox

Since Specialization
Citations

This map shows the geographic impact of DA Cox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by DA Cox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites DA Cox more than expected).

Fields of papers citing papers by DA Cox

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by DA Cox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by DA Cox. The network helps show where DA Cox may publish in the future.

Co-authorship network of co-authors of DA Cox

This figure shows the co-authorship network connecting the top 25 collaborators of DA Cox. A scholar is included among the top collaborators of DA Cox based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with DA Cox. DA Cox is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Kegley, Susan E., et al.. (2024). Longitudinal Analysis of Honey Bee Colony Health as a Function of Pesticide Exposure. Agronomy. 14(11). 2505–2505.
2.
Sorajja, Paul, Bernard J. Gersh, DA Cox, et al.. (2007). Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction. European Heart Journal. 28(14). 1709–1716. 351 indexed citations
3.
Stone, Gregg W., et al.. (2004). A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. Journal of Vascular Surgery. 39(5). 1142–1142. 94 indexed citations
4.
Bakhai, Ameet, et al.. (2002). Cost-effectiveness of coronary stenting and abciximab for patients with AMI: Results from the CADILLAC trial. Circulation. 106(19). 518–518. 1 indexed citations
5.
Cox, DA, et al.. (2001). A prospective, multicenter, international randomized trial comparing four reperfusion strategies in acute myocardial infarction: Principal report of the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial. Journal of the American College of Cardiology. 37(2). 5 indexed citations
6.
Cox, DA, et al.. (1986). The antihypertensive effects of doxazosin: a clinical overview.. British Journal of Clinical Pharmacology. 21(S1). 83S–90S. 59 indexed citations
7.
Cox, DA, et al.. (1983). Effects of acetylcholine on large and small coronary arteries in conscious dogs.. Journal of Pharmacology and Experimental Therapeutics. 225(3). 764–769. 29 indexed citations
8.
Cox, DA, Thomas Patrick, & Stephen F. Vatner. (1981). Myocardium salvaged by coronary artery reperfusion responds appropriately to cardiovascular stress.. PubMed. 94. 333–40. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026